Tri‐modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell‐free DNA using machine learning algorithm

Tri‐modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell‐free DNA using machine learning algorithm

Bibliographic Details
Main Authors:	Jiyoon Bu, Tae Hee Lee, Michael J. Poellmann, Piper A. Rawding, Woo‐Jin Jeong, Rachel S. Hong, Sung Hee Hyun, Hyuk Soo Eun, Seungpyo Hong
Format:	Article
Language:	English
Published:	Wiley 2021-08-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.499

Similar Items

Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer.
by: Jiyoon Bu, et al.
Published: (2020-01-01)

Cytochalasin B Treatment and Osmotic Pressure Enhance the Production of Extracellular Vesicles (EVs) with Improved Drug Loading Capacity
by: Ashita Nair, et al.
Published: (2021-12-01)

Multi-modal liquid biopsy platform for cancer screening: screening both cancer-associated rare cells and cancer cell-derived vesicles on the fabric filters for a reliable liquid biopsy analysis
by: Jiyoon Bu, et al.
Published: (2019-11-01)

Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)
by: Taehee Lee, et al.
Published: (2022-04-01)

Hierarchically Multivalent Peptide–Nanoparticle Architectures: A Systematic Approach to Engineer Surface Adhesion
by: Woo‐jin Jeong, et al.
Published: (2022-02-01)

Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
by: Wei Zhang, et al.
Published: (2017-02-01)

The Specific Gravity-Free Method for the Isolation of Circulating Tumor KRAS Mutant DNA and Exosome in Colorectal Cancer
by: Tae Hee Lee, et al.
Published: (2021-08-01)

Fabrication of Formalin-Fixed, Paraffin-Embedded (FFPE) Circulating Tumor Cell (CTC) Block Using a Hydrogel Core-Mediated Method
by: Tae Hee Lee, et al.
Published: (2021-09-01)

Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
by: Marta Tellez-Gabriel, et al.
Published: (2020-12-01)

Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis
by: Melissa Skibba, et al.
Published: (2020-12-01)

Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?
by: Woo-jin Jeong, et al.
Published: (2018-12-01)

Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer
by: An Zhao, et al.
Published: (2019-07-01)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01)

Circulating Exosomes Inhibit B Cell Proliferation and Activity
by: Jan C. Schroeder, et al.
Published: (2020-07-01)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Qianwei Ye, et al.
Published: (2019-07-01)

Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy
by: Hyunjong Lee, et al.
Published: (2022-08-01)

Clinical performance of Ambu AuraGainTM versus i-gelTM in anesthetized children: a prospective, randomized controlled trial
by: Ji-Hyun Lee, et al.
Published: (2020-04-01)

PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells
by: Tae Woo Kim, et al.
Published: (2021-06-01)

Long-Term Tri-Modal In Vivo Tracking of Engrafted Cartilage-Derived Stem/Progenitor Cells Based on Upconversion Nanoparticles
by: Chu-Hsin Chen, et al.
Published: (2021-06-01)

A transgenic tri-modality reporter mouse.
by: Xinrui Yan, et al.
Published: (2013-01-01)

High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery
by: Etienne Buscail, et al.
Published: (2019-10-01)

Mesenchymal Stem Cell-Derived Exosomes and Their Therapeutic Potential for Osteoarthritis
by: Gi Beom Kim, et al.
Published: (2021-04-01)

Stem Cell-Derived Exosomes and Nanovesicles: Promotion of Cell Proliferation, Migration, and Anti-Senescence for Treatment of Wound Damage and Skin Ageing
by: Hyeonjin Cha, et al.
Published: (2020-11-01)

UBA6 Inhibition Accelerates Lysosomal TRPML1 Depletion and Exosomal Secretion in Lung Cancer Cells
by: Dongun Lee, et al.
Published: (2024-02-01)

Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
by: José Pedro Sequeira, et al.
Published: (2021-10-01)

Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes
by: Mohammed Nimir, et al.
Published: (2019-07-01)

Mesenchymal Stem Cell Exosomes Derived from Feline Adipose Tissue Enhance the Effects of Anti-Inflammation Compared to Fibroblasts-Derived Exosomes
by: Soo-Eun Sung, et al.
Published: (2021-09-01)

On‐Chip Biogenesis of Circulating NK Cell‐Derived Exosomes in Non‐Small Cell Lung Cancer Exhibits Antitumoral Activity
by: Yoon‐Tae Kang, et al.
Published: (2021-03-01)

Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma
by: Xing He, et al.
Published: (2022-08-01)

A novel PPARɣ ligand, PPZ023, overcomes radioresistance via ER stress and cell death in human non-small-cell lung cancer cells
by: Tae Woo Kim, et al.
Published: (2020-10-01)

Cytopathological Study of the Circulating Tumor Cells filtered from the Cancer Patients’ Blood using Hydrogel-based Cell Block Formation
by: Yoon-Tae Kang, et al.
Published: (2018-10-01)

Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics
by: Lisa Welter, et al.
Published: (2023-08-01)

Presence of Urinary Exosomes for Liquid Biopsy of Clear Cell Renal Cell Carcinoma: Protocol for a Pilot Feasibility Study
by: Guorong Li, et al.
Published: (2021-07-01)

Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)
by: Trevor J. Mathias, et al.
Published: (2020-03-01)

Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial
by: Edward Yu, et al.
Published: (2022-07-01)

Tri-modal management of primary small cell carcinoma of the pancreas (SCCP): a rare neuroendocrine carcinoma (NEC)
by: Safa Elzein, et al.
Published: (2021-09-01)

Using tyrosinase as a tri-modality reporter gene to monitor transplanted stem cells in acute myocardial infarction
by: Mei Liu, et al.
Published: (2018-04-01)

Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells
by: Keun-Yeong Jeong, et al.
Published: (2018-04-01)

Nano-scale characterisation of tri-modal microstructures in TIMETAL® 575
by: Frutos-Myro Enrique, et al.
Published: (2020-01-01)

Bandwidth Enhancement Technique for Broadside Tri-Modal Patch Antenna
by: Chi-Yuk Chiu, et al.
Published: (2020-01-01)